What is your current role on AMYPAD?

I joined the AMYPAD project in February 2018 as the Project Manager for AMYPAD Diagnostic and Patient Management Study, in the team of Prof. Frisoni at UNIGE. My role is to coordinate the set-up of the study in eight sites so that the submission processes can be completed and sites can start to recruit patients. Now that this is completed in Geneva, I work on the follow-up with participating sites needs to ensure that the study is moving forward according to plans.

What is your overall vision?

I joined the AMYPAD team at a critical moment: the protocol was just approved in Geneva and the last administrative constraints had to be cleared to move from the theoretical side of a clinical protocol to the reality of including patients in the study. I am so happy that I was able to recruit the first patient myself, here at University of Geneva, launching the operational phase of the trial. It made me step in a project that is, and will be, a strong driver in Alzheimer’s disease management, improving patient’s quality of life in the future.

What do you find most challenging about the project?

The main challenge was to join an ongoing project at a very specific time point: looking for the first patient. In Geneva, our role is to be the “pathfinder” for the other sites. In addition, the study is spread over 8 countries, with each their own specificities! It was, and it still is a great challenge trying to learn from all these teams and work with all of them to align on shared decisions in order to continue moving forward.